| 000 | 01035 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250512010608.0 | ||
| 264 | 0 | _c19900125 | |
| 008 | 199001s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/00007691-198911000-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLarsen, N E | |
| 245 | 0 | 0 |
_aPrediction of the optimal perphenazine decanoate dose based on blood samples drawn within the first three weeks. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cNov 1989 |
||
| 300 |
_a642-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPerphenazine _xadministration & dosage |
| 700 | 1 | _aHansen, L B | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 11 _gno. 6 _gp. 642-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007691-198911000-00005 _zAvailable from publisher's website |
| 999 |
_c2601641 _d2601641 |
||